Shenzhen Liying Biotechnology Co., Ltd announced that it has received tens of millions in its Angel + rounds of financing, led by new investor, Goldport Capital on April 6, 2023. The transaction included participation from new investors, Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd., industry parties and other investment institutions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.88 CNY | -2.04% | +3.51% | -17.79% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
28.88 CNY | -2.04% | +3.51% | 904M | ||
28.32 CNY | +4.46% | +13.28% | 1.33B | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.79% | 904M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- 002880 Stock
- News Shenzhen Weiguang Biological Products Co., Ltd.
- Shenzhen Liying Biotechnology Co., Ltd announced that it has received funding from Goldport Capital, Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen Dymind Biotechnology Co.,Ltd, Wuxi Best Precision Machinery Co., Ltd. and other investors